No Data
Wall Street Analysts Predict a 54.95% Upside in Immatics (IMTX): Here's What You Should Know
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
Houston, Texas and Tuebingen, Germany, July 18, 2024 – Immatics N.V. (NASDAQ: IMTX, "Immatics"), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-
Memo Therapeutics AG Appoints Paul Carter as Chairperson
PRESS RELEASE Memo Therapeutics AG appoints Paul Carter as Chairperson Virology and commercial expertise will support Phase III readiness and commercial preparations of AntiBKV Extensive public and private market
Here's Why We Think Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Looks Fair for the Time Being
Key Insights Immatics' Annual General Meeting to take place on 20th of June CEO Harpreet Singh's total compensation includes salary of €488.0k Total compensation is similar to the industry average
We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring reve
12 Health Care Stocks Moving In Friday's Intraday Session
GainersInnovative Eyewear (NASDAQ:LUCY) shares increased by 328.8% to $0.8 during Friday's regular session. The market value of their outstanding shares is at $13.9 million. OneMedNet (NASDAQ:ONMD) sh
MARKET-TEST-DUMMYOP :